Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.88p
   
  • Change Today:
      0.000p
  • 52 Week High: 19.00
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 226.75m
  • Volume: 37,131
  • Market Cap: £13.32m

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2940.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 35.7 n/a
Pr/Book 2.0  
Latest F'cast
Revenue -75.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.79 (16.27) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.64 (19.37) (10.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

Corporate and Trading Update 24-Apr-2024 07:00 RNS
Appointment of Interim Chief Financial Officer 28-Mar-2024 12:52 RNS
First commercial adoption of Steriwave by the NHS 25-Mar-2024 07:00 RNS

OBI ShareCast News

Ondine reports significant financial growth 24-Apr-2024 ShareCast
Ondine Biomedical assessing Steriwave with Yorks... 05-Mar-2024 ShareCast
Ondine raises $3.6m to help commercialise Steriw... 13-Dec-2023 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 5.88p
Change Today 0.000p
% Change 0.00 %
52 Week High 19.00
52 Week Low 5.75
Volume 37,131
Shares Issued 226.75m
Market Cap £13.32m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.55% below the market average45.55% below the market average45.55% below the market average45.55% below the market average45.55% below the market average
62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average
Price Trend
91.85% below the market average91.85% below the market average91.85% below the market average91.85% below the market average91.85% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Income Not Available
Growth
45.71% below the market average45.71% below the market average45.71% below the market average45.71% below the market average45.71% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

OBI Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
11:00 6,063 @ 6.00p
11:00 3,064 @ 6.00p
11:00 2,999 @ 6.00p
10:59 1,434 @ 6.00p
10:11 5,617 @ 5.78p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page